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Abstract
Background: Although postmenopausal associated disorders are important public health problems worldwide, to date limited 
studies evaluated the endothelial function and systemic inflammation response to weight loss in obese postmenopausal women. 
Objective: This study was done to evaluate the endothelial function and systemic inflammation response to weight loss in obese 
postmenopausal Saudi women. 
Material and methods: Eighty postmenopausal obese Saudi women (mean age 52.64±6.13 year) participated in two groups: 
Group (A) received aerobic exercise on treadmill and diet whereas, group (B) received no intervention. Markers of  inflammation 
and endothelial function were measured before and after 3 months at the end of  the study. 
Results: The values of  body mass index(BMI), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), C-reactive protein 
(CRP), inter-cellular adhesion molecule (ICAM-1), vascular cell adhesion molecule (VCAM-1) and plasminogen activator inhibi-
tor-1 activity (PAI-1:Ac) were significantly decreased in group (A), while changes were not significant in group (B). Also, there 
were significant differences between mean levels of  the investigated parameters in group (A) and group (B) after treatment. 
Conclusion: Weight loss ameliorates inflammatory cytokines and markers of  endothelial function in obese postmenopausal 
Saudi women.
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Introduction
Globally, the number of  menopausal women is increased 
as the proportion of  geriatric population is expected to 
be increased from 12% up to 20% by 20501,2 correlated 
with increased prevalence of  obesity, which is currently 
considered to be an epidemic3 as obesity and overweight 
affect about two-third of  population worldwide4. Obesity 
has many co-morbidities as cancer, osteoarthritis, cardio-
vascular, respiratory and type 2 diabetes5-8.
Endothelial dysfunction is considered as an early predic-
tor of  various cardiovascular disorders such as athero-
sclerosis and heart attack and has been implicated in the 
pathogenesis of  diabetes-induced angiopathy9. Athero-
sclerosis is a leading cause of  morbidity includes periph-
eral vascular disorders, stroke and ischemic heart disease, 
however, and mortality in diabetic patients. Endothelial 
dysfunction is considered an initial dysfunction of  blood 
vessels and an important predictor of  atherosclerosis in 
diabetic patients10-12.
Aerobic exercises associated with appropriate diet regi-
men were reported to protect against atherosclerosis 
in non-insulin dependent diabetes mellitus13. However, 
weight reduction program modulates markers of  sys-
temic inflammation, endothelial function and adipokines 
which are usually associated with better cardiovascular 
system prognosis in obese subjects14,15.
The aim of  this study was to evaluate the endothelial 
function and systemic inflammation response to weight 
loss in obese postmenopausal Saudi women. 
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Materials and methods
Subjects
Eighty obese postmenopausal Saudi women were en-
rolled in the present randomized controlled trial, and-
were selected from the Internal Medicine Department at 
King Abdul Aziz University Hospital and other Hospitals 
in Jeddah area. Inclusion criteria of  this study were the 
following: (1) postmenopausal women aged 47-58 years; 
(2) a sedentary lifestyle (not exercising > 30 minutes on 
>3 day/week) for the past 6 months; and (3) not taking 
any medication including lipid lowering agents, nonste-
roidal anti-inflammatory drugs, antihypertension drugs, 
and hormone-replacement therapy. Exclusion criteria in-
cluded patients suffering from congestive heart failure; 
uncontrollable cardiac arrhythmias, hypertension, muscu-
loskeletal disorders, and intake of  medications affect the 
endothelial function. Participants were sub divided into 
two groups; group (A) received treadmill aerobic exercise 
training and diet regimen. Group (B) received no exercise 
training and no diet regimen. The original sample con-
sisted of  184 participants who underwent the eligibility 
assessment. In the enrollment phase, 63 of  them were 
excluded as they didn’t meet inclusion criteria  and 18 re-
fused to participate, then randomization was done. This 
substudy thus included 103 subjects (53 patients in the 
intervention group and 50 patients in the control group). 
During the follow up,  in the intervention group 7 pa-
tients discontinued intervention (4 patients disliked the 
diet regimen, 2 patients had work related schedule prob-
lems and 1 patient discontinued due to unknown reason) 
and in the control group 6 patients discontinued interven-
tion (4 patients had work related schedule problems and 
2 patient discontinued due to unknown reasons).In addi-
tion, 6 patients in the intervention group and 4 patients 
in the control group were excluded from the analysis due 
to insufficient blood sample. This study was approved by 
the Ethical Committee for Scientific Research, Faculty of  
Applied Medical Sciences, King Abdulaziz University. All 
participants provided written informed consent.
 
Measurements
A. Measurement of  biomarkers of  endothelial func-
tion: Biomarkers of  endothelial function included ad-
hesion molecules which included inter-cellular adhesion 
molecule (ICAM-1), vascular cell adhesion molecule 
(VCAM-1) and the fibrinolytic molecule (plasmino-
gen activator inhibitor-1 activity, PAI-1:Ac). These were 
measured from frozen serum samples stored at −80 °C. 
Enzyme-linked immunosorbent assays(ELISAs) were 
used to measure soluble levels of  ICAM-1 and VCAM-1 
(R&D Systems, USA), and PAI-1: Ac (Hyphen BioMed 
for PAI-1, France).
B. Measurement of  inflammatory cytokines: Venous 
blood samples after a 12-hours fasting were centrifuged 
at 4 °C (1000 = g for 10 min). Interleukin-6 (IL-6) levels 
were analyzed by “Immulite 2000” immunassay analyzer 
(Siemens Healthcare Diagnostics, Deerfield, USA). How-
ever, tumor necrosis factor-alpha (TNF-α) and C-reactive 
protein (CRP) levels were measured by ELISA kits (R&D, 
USA) by using ELISA technique (ELX 808; BioTek In-
struments, USA).
C. Measurement of  Anthropometric Parameters: For 
all participants their height was measured with a digital 
stadio-meter to the nearest 0.1 cm (JENIX DS 102, S. 
Korea). The participants were measured while wearing 
their undergarments and hospital gowns. Body weight 
was measured on a calibrated balance scale to the nearest 
0.1 kg (HC4211, S. Korea), and body mass index (BMI) 
was calculated as body weight/Height2.
 All measurements of  BMI, IL-6, TNF-α, CRP, ICAM-1, 
VCAM-1 and PAI-1: Ac were taken before the starting of  
the study (pre-test) and after three months at the end of  
the study (post-test).
Procedures
All patients were divided randomly into the following 
groups:
1. The training group (Group A): Patients were submit-
ted to the aerobic exercise training to complete a 12-week 
aerobic exercise-training program on a treadmill aerobic 
exercise (Enraf  Nonium, Model display panel Standard, 
NR 1475.801, Holland). Each session of  physical exercise 
was divided in: 5 minutes of  warm up, with stretching ex-
ercises and circling of  members and body; 30 minutes of  
aerobic exercise divided into row ergometer (15 minutes) 
and bicycle ergometer (15 minutes) and 5 minutes of  cold 
down at the end, with stretching, flexibility and relaxation 
exercises, consisting of  five sessions per week. The train-
ing program was performed at 70% of  the individual age-
predicted HRmax
16. In addition, a dietician performed an 
interview-based food survey for all participants of  group 
(A) for detection of  feeding habits, abnormal dietary be-
havior and to prescribe the balanced low calorie that pro-
vide 1200 kilocalories/day for 12 weeks.
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2. The control group (Group B):  Patients maintained 
their ordinary life style and received no exercise and diet 
regimen training.
Statistical analysis
All results are shown as means ± SD. The mean values 
of  the investigated parameters obtained before and af-
ter training program in both groups were compared us-
ing paired "t" test. Independent "t" test was used for the 
comparison between the two groups (P<0.05).
Results
The two groups were considered homogeneous regard-
ing the baseline clinical variables (Table 1). 
 




Significance Intervention group 
(n = 40) 
Control group 
 (n = 40) 
Age (year) 51.17±5.63 50.41±5.27 P > 0.05 
Weight (kg) 90.82 ± 6.84 91.13± 6.51 P > 0.05 
Height (cm) 168.93± 7.72 170.76 ± 8.15 P > 0.05 
Waist-hip ratio 0.85±0.07 0.87 ± 0.08 P > 0.05 
BMI (kg/m2) 33.71± 3.12 34.11± 3.54 P > 0.05 
SBP (mm Hg) 122.56± 8.17 124.18± 7.96 P > 0.05 
DBP (mm Hg) 83.42± 4.31 84.21± 4.92 P > 0.05 
TC  (mg/dl) 195.35±10.32 197.14±11.18 P > 0.05 
LDL-c  (mg/dl) 134.44 ±8.91 135.32 ±8.87 P > 0.05 
TG   (mg/dl) 155.20±10.41 157.16 ±10.16 P > 0.05 
HDL-c  (mg/dl) 36.31 ±2.97 35.94 ±2.85 P > 0.05 
HOMA-IR 2.87 ± 2.62 2.76 ± 2.81 P > 0.05 
 
BMI: Body mass index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; TC: Total cholesterol; 
HOMA-IR: Homeostasis Model Assessment-Insulin Resistance Index; LDL-c: Low-density lipoprotein 
cholesterol;  TG: Triglyceride; HDL-c: High-density lipoprotein cholesterol.     
There was a 36.9%, 48.8%, 43.1%, 9.8%, 10.7%, 25.9% 
and 10.5% reduction in mean values of  IL-6, TNF-α, 
CRP, ICAM-1, VCAM-1, PAI-1and BMI respectively in 
group (A) at the end of  the study. The mean value of  
BMI, IL-6, TNF-α, CRP, ICAM-1, VCAM-1 and PAI-
1: Ac was significantly decreased in group (A) (Table 2), 
while changes were not significant in group (B) (Table 3). 
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Table (2): Mean value and significance of BMI, TNF-α, IL-6, CRP, ICAM-1, 
VCAM-1 and PAI-1: Ac in group (A) before and at the end of the study. 
 
  Mean ±SD Significance 
Before the study At the end of the study 
BMI (kg/m2) 33.71± 3.12 30.17 ± 2.98* P < 0.05 
TNF- α (pg/mL) 12.85 ± 2.74 8.11 ± 2.65* P < 0.05 
IL-6 (pg/mL) 5.63 ± 1.42 3.16 ± 1.36* P < 0.05 
CRP ( mg/L) 4.13±  1.13 2.35± 0.97* P < 0.05 
ICAM-1 (ng/ml) 93.78±16.93 84.54±15.16* P < 0.05 
VCAM-1 (ng /ml) 821.93±54.98 734.22±51.73* P < 0.05 
PAI-1: Ac (ng/ml) 0.54 ±0.17 0.40 ±0.13* P < 0.05 
 
BMI: Body mass index; TNF- α: tumor necrosis factor – alpha; IL-6: Interleukin-6; CRP: C- reactive protein; 
ICAM-1: Inter-Cellular Adhesion Molecule; VCAM-1: Vascular Cell Adhesion Molecule; PAI-1: Ac: Plasminogen 
Activator Inhibitor-1 Activity; (*) indicates a significant difference between the two groups, P < 0.05. 
 
Table (3): Mean value and significance of BMI, TNF-α, IL-6, CRP, ICAM-1, 
VCAM-1 and PAI-1: Ac in group (B) before and at the end of the study. 
 
  Mean +SD Significance 
Before the study At the end of the study 
BMI (kg/m2) 34.11± 3.54 34.31± 3.59 P > 0.05 
TNF- α (pg/mL) 12.96± 2.65 12.12± 2.74 P > 0.05 
IL-6 (pg/mL) 5.89 ± 1.58 5.93 ± 1.60 P > 0.05 
CRP ( mg/L) 4.53±  1.27 4.58±  1.28 P > 0.05 
ICAM-1 (ng/ml) 94.16±14.52 94.25±14.57 P > 0.05 
VCAM-1 (ng /ml) 825.12±52.74 826.81±52.69 P > 0.05 
PAI-1: Ac (ng/ml) 0.58 ±0.19 0.62 ±0.21 P > 0.05 
 
BMI: Body mass index; TNF- α: tumor necrosis factor – alpha; IL-6: Interleukin-6; CRP: C- reactive protein; 
ICAM-1: Inter-Cellular Adhesion Molecule; VCAM-1: Vascular Cell Adhesion Molecule; PAI-1: Ac: Plasminogen  
In addition, there were significant differences between 
mean levels of  the investigated parameters in group (A) 
and group (B) at the end of  the study (Table 4).
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Table (4): Mean value and significance of BMI, TNF-α, IL-6, CRP, ICAM-1, 
VCAM-1 and PAI-1: Ac in group (A) and group (B) at the end of the study. 
 
  Mean +SD Significance 
Group (A) Group (B) 
BMI (kg/m2) 30.17 ± 2.98* 34.31± 3.59 P < 0.05 
TNF- α (pg/mL) 8.11 ± 2.65* 12.12± 2.74 P < 0.05 
IL-6 (pg/mL) 3.16 ± 1.36* 5.93 ± 1.60 P < 0.05 
CRP ( mg/L) 2.35± 0.97* 4.58±  1.28 P < 0.05 
ICAM-1 (ng/ml) 84.54±15.16* 94.25±14.57 P < 0.05 
VCAM-1 (ng /ml) 734.22±51.73* 826.81±52.69 P < 0.05 
PAI-1: Ac (ng/ml) 0.40 ±0.13* 0.62 ±0.21 P < 0.05 
 
BMI: Body mass index; TNF- α: tumor necrosis factor – alpha; IL-6: Interleukin-6; CRP: C- reactive protein; 
ICAM-1: Inter-Cellular Adhesion Molecule; VCAM-1: Vascular Cell Adhesion Molecule; PAI-1: Ac: Plasminogen 
Activator Inhibitor-1 Activity; (*) indicates a significant difference between the two groups, P < 0.05. 
Discussion
There is a high prevalence of  obesity among Saudi post-
menopausal women that reached 39.3% among diabetics 
as compared to 18.5% among non-diabetics17. The popu-
lation of  Saudi Arabia with changes in lifestyle, reduc-
tion of  physical activity and high calorie snacks and foods 
have led to increased prevalence of  obesity18. Obesity is 
an independent risk factor for cardiovascular disorders 
that may be related to abnormal levels of  inflammatory 
cytokines and endothelial dysfunction10-12. 
The American Heart Association recommended weight 
loss to reduce the severity of  cardiovascular risk factors in 
overweight and obese patients19. However, little is known 
about the effect of  lifestyle intervention on inflammatory 
cytokines and circulating levels of   endothelial function 
biomarkers among obese postmenopausal Saudi women. 
The main finding of  the present study was that weight-
reducing program ameliorated inflammatory cytokines 
(TNF-α, IL-6 and CRP) and markers of  endothelial func-
tion (ICAM-1 VCAM-1 and tPA) in obese postmeno-
pausal women as a result of  weight loss, these results are 
in line with many previous studies. Cotie and colleagues 
demonstrated that, sixteen weeks of  a combined train-
ing by aerobic and resistance exercises in addition to diet 
resulted in improved interleukin-6 (IL-6) and endothelial 
function in overweight and obese young women because 
of  weight loss20.
Lang and colleagues established that a weight-reducing 
program had anti-atherogenic and inflammatory effects 
in their study on three obese men and eleven obese wom-
en for eight weeks21. Choo and colleagues proved that 
weight-reducing program in the form of  diet regimen for 
three months followed by diet regimen added to exercise 
intervention for nine months had a remarkable reduction 
in the risk of  cardio-metabolic and subclinical atheroscle-
rosis22. Madsen and colleagues stated that inflammatory 
markers were reduced significantly if  body weight was re-
duced by 10% in obese subjects23. Esposito et al. suggest-
ed that weight-reducing program for 2 years significantly 
reduced C-reactive protein24. In addition, Nicklas and 
colleagues stated that 12 months life style modification 
program significantly reduced TNF-α level in obese in-
dividuals25. Loria-Kohen and colleagues conducted their 
study on 84 overweight participants completed 22 weeks 
of  different exercises programs in addition to diet con-
trol. The CRP and TNF-α have shown reduction values 
in all study groups26.
                                                                                                         
Sheu and colleagues reported that 5% of  body weight 
loss obtained after 12 weeks of  caloric restriction and ex-
ercises resulted in significant reduction in  TNF-α and 
IL-6 of  obese women27. However, Rokling-Andersen and 
colleagues studied the impact of  one-year diet regimen 
alone or in association with exercises and found a signifi-
cant improvement in TNF-α and adiponectin28 and CRP 
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in both groups. Silverman and colleagues conducted their 
study on obese postmenopausal women who participated 
in a six months hypo-caloric diet or hypo-caloric diet plus 
walking program, they concluded that addition of  aerobic 
exercises to hypo-caloric diet is recommended to modu-
late TNF-α  and IL-6 and increase bone marrow density29. 
Imayama and colleagues examined the effects of  a caloric 
restriction weight loss diet and exercise on inflammatory 
biomarkers in 439 obese postmenopausal women were 
randomized to one year: caloric restriction diet (goal of  
10% weight loss, N=118), aerobic exercise (225 minutes/
week of  moderate-to-vigorous activity, N=117), com-
bined diet plus exercise (N=117) or control (N=87), 
findings indicated that a caloric restriction weight loss 
diet with or without exercise reduces biomarkers of  in-
flammation (CRP and IL-6) in postmenopausal women30. 
Garanty-Bogacka et al. applied a study on fifty six obese 
adolescents, participating in an obesity intervention pro-
gram, they were studied before and after 1 year program 
consisting of  moderate physical activity (exercise group 
including 37 participants) or hypo-caloric diet (diet group: 
19 subjects) and concluded that moderate-intensity train-
ing alone reduced IL-6 and CRP in obese adolescents 
more than observed after caloric restriction31. In addition, 
bariatric surgery decreased CRP ,IL-6 and increased the 
circulating level of  adiponectin32-36. Reductions in pro-
inflammatory cytokines concentrations after weight loss 
is explained by reduction in fat mass37.
 
Concerning the markers of  endothelial function, the ob-
servation in this study indicated a significant reduction in 
VCAM-1, ICAM-1 and PAI-1 because of  weight loss at 
the end of  the study. Nevertheless, the current data is in 
line with many studies conducted in obese subjects having 
observed reduction in PAI-138-41, VCAM-141 and ICAM-
141-43 following weight loss. Sharman and Volek conclud-
ed that a six weeks hypo-caloric diet resulted in reduction 
in ICAM-1, CRP, IL-6, TNF-α44 and PAI-1 after 12 weeks 
in overweight subjects45. Thomson and colleagues prove 
that a 12 week of  hypo-caloric diet of  high protein diet 
with or without exercise training resulted in significant re-
duction in ICAM-1, VCAM-1 and PAI-1 levels associated 
with weight loss in obese women with polycystic ovary 
syndrome46. Haspicova and colleagues conducted a study 
on forty obese premenopausal women had reduction in 
plasma VCAM-1 and ICAM-1 because of  4-week very 
low caloric diet (800 kcal/day)47. Furthermore, there is 
indirect evidence based on plasma markers ICAM and E-
selectin that were improved by weight-loss48. In addition, 
bariatric surgery resulted in improvement in endothelial 
function49,50. The mechanisms of  endothelial dysfunc-
tion modulation are not clearly elucidated, however many 
studies suggest that reduction in oxidative stress and 
markers of  endothelial activation51,52 as well as increases 
in nitrous oxide bioavailability through repeated increase 
of  shear stressmayserve as mechanisms53,54.
 
The current study has important strengths and limita-
tions. The major strength is the supervised nature of  
the study. Supervising food intake and physical activity 
removes the need to question compliance or to rely on 
food and activity questionnaires. Furthermore, all exer-
cise sessions were supervised and adherence to the diet 
and activities was essentially 100%. Moreover, the study 
was randomized; hence, we can extrapolate adherence 
to the general population. On the other hand, the major 
limitation is only postmenopausal women enrolled in the 
study ,so the value of  this study only related to women in 
this age group , also a small sample size in both groups 
may limit the possibility of  generalization of  the find-
ings in the present study. Finally, within the limit of  this 
study, weight reduction is recommended for  modulation 
of  low grade systemic inflammation and endothelial dys-
function among obese postmenopausal women. Further 
researches are needed to explore the impact of  weight 
reduction on quality of  life and other biochemical param-
eters among postmenopausal women.
 
Conclusion
Weight loss ameliorates inflammatory cytokines and 
markers of  endothelial function in obese postmenopaus-
al Saudi women.
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